BusinessStem Cell TherapyFURESTEM-AD® Inj.
FURESTEM-AD® Inj. is the world’s first stem cell therapeutic product for atopic dermatitis that targets moderate to severe atopic dermatitis patients.
  • Product name : FURESTEM-AD® Inj.
  • Manufacturer : Kangstem Biotech
  • Target : Moderate to severe atopic dermatitis patients
  • Injection route : Subcutaneous injection

MoA : IL-4 is secreted from Th2 cells. FURESTEM-AD® Inj. is stimulated by IL-4. Stimulated FURESTEM-AD® Inj. secretes TGF-β1. TGF-β1 suppresses expression of FcεR1 receptor (during maturation of mast cells). FURESTEM-AD® Inj. secretes PGE2. PGE2 suppresses degranulation of mast cells. FURESTEM-AD® Inj. inhibits each step of mast cell activation and degranulation through the secretions of TGF-β1 & PGE2.

whatwedo : furestemAD : : : /whatwedo/furestemAD